艾本与骨膦治疗非小细胞肺癌骨转移的疗效比较

郭琛; 郭其森; 齐洁琳; 刘群; 吴宁

艾本与骨膦治疗非小细胞肺癌骨转移的疗效比较

山东省肿瘤医院内一科, 济南市 250117

详细信息

通讯作者:
郭其森

中图分类号: R734.2
计量
- 文章访问数: 3
- HTML全文浏览量: 0
- PDF下载量: 1
出版历程
- 修回日期: 2008-01-20
- 发布日期: 2008-03-30

Comparison of the Effects of Ibandronate and Bonefos on Non small Cell Lung Cancer with Bone Metastases

The First Department of Internal Medicine, Shandong Tumor Hospital, Jinan 250117, China

摘要

摘要: 目的: 评价国产伊班膦酸钠(艾本)治疗非小细胞肺癌骨转移的临床疗效并探讨安全性。同时与骨膦进行疗效和不良反应的比较,寻找更优的治疗方法。 方法: 将山东省肿瘤医院2003年11月至2006年11月间86例非小细胞肺癌骨转移患者随机分为两组:艾本组44例和骨膦组42例。艾本应用4mg加入500ml生理盐水中静脉滴注2h,每4周应用1次。骨膦应用300mg加入500ml生理盐水中静脉滴注3h,连用5天后改为口服800mg,2次/日,30天为1个周期。化疗方案均选择以顺铂为基础的两药联合方案。治疗2个疗程结束后观察3个月并评价疗效。 结果: 两组在止痛、活动能力改善和对骨转移灶的有效率方面进行比较,艾本组有效率分别为81.8%(36/44)、68.2%(30/44)和52.3%(23/44),骨膦组分别为73.8%(31/42)、76.2%(32/42)和45.2%(19/42),两组相比差异无统计学意义(P>0.05)。患者用药后一般情况有所改善。不良反应主要表现为一过性发热、消化道反应、骨髓抑制、乏力、四肢肌肉酸痛等,无治疗相关性死亡。 结论: 艾本治疗非小细胞肺癌骨转移与骨膦疗效和不良反应相当,应用艾本更为方便快捷。
- 艾本 /
- 骨膦 /
- 骨转移 /
- 化疗 /
- 非小细胞肺癌
Abstract: Objective: To evaluate the clinical efficacy and safety of Ibandronate and Bonefos for nonsmall celllung cancer (NSCLC) with bone metastases. Methods: A total of 86 NSCLC patients with bone metastases were randomlydivided into two groups: 44 in the Ibandronate group and 42 in the Bonefos group. The chemotherapy in both groups was Cisplatinbased. The therapeutic efficacy was evaluated after 2 cycles of treatment, with 21 days for each cycle. Results: The response rate of pain relief, improvement in daily living and effective rate on bone metastatic foci was 81.8% (36/44),68.2%(30/44) and 52.3%(23/44), respectively, in the Ibandronate group and 73.8%(31/42), 76.2%(32/42) and 45.2% (19/42), respectively, in the Bonefos group. No significant difference was found between the two groups (P>0.05). The side effects could be tolerated. Conclusion: The effects of Ibandronate and Bonefos on NSCLC patients with bone metastasescomparable. The administration of Ibandronate is more convenient.
- Ibandronate /
- Bonefos /
- Bone metastasis /
- Chemotherapy /
- Nonsmall cell lung cancer(NSCLC)

HTML全文

参考文献(13)

[1]	Coleman RE. Bisphosphonates: clinical experience [J]. Oncologist,2004, 9 Suppl 4: 14～27
[2]	周际昌, 主编. 实用肿瘤内科学 [M]. 第二版. 北京 : 人民卫生出版社,2005.45～47
[3]	尤健, 阚学峰, 王长利.13 例非小细胞肺癌肋骨转移的外科治疗[J]. 中国肿瘤临床,2007,34(2):86～88
[4]	Sohara Y, Shimada H, DeClerck YA. Mechanisms of bone inva-sion and metastasis in human neuroblastoma [J]. Cancer Lett J,2005, 228(1～2): 203～209
[5]	Zheng Y, Zhou H, Brennan K, et al. Inhibition of bone resorp-tion, rather than direct cytotoxicity, mediates the antitumour ac-tions of ibandronate and osteoprotegerin in a murine model ofbreast cancer bone metastasis[J]. Bone, 2007, 40(2): 471～478
[6]	Antr&s L, Smith M, Neary MP, et al. Presented at the 8th andValedictory Workshop on Bisphosphonates [M]. Davos Switzer-land, 2006. 22～24
[7]	Kiagia M, Karapanagiotou E, Charpidou A, et al. Rapid infusionof ibandronate in lung cancer patients with bone metastases[J].Anticancer Res, 2006, 26(4B): 3133～3136
[8]	Pecherstorfer M, Rivkin S, Body JJ, et al. Longterm safety of in-travenous ibandronic acid for up to 4 years in metastatic breastcancer: an openlabel trial [J]. Clin Drug Investig, 2006, 26(6):315～322
[9]	Felsenberg D, Miller P, Armbrecht G, et al. Oral ibandronate sig-nificantly reduces the risk of vertebral fractures of greater severityafter 1, 2, and 3 years in postmenopausal women with osteoporo-sis[J]. Bone, 2005, 37(5): 651～654
[10]	Reginster JY, Adami S, Lakatos P, et al. Efficacy and tolerability ofoncemonthly oral ibandronate in postmenopausal osteoporosis: 2year results from the MOBILE study [J]. Ann Rheum Dis, 2006,65(5): 654～661
[11]	Bergner R, Henrich D, Hoffmann M, et al. High bonebindingcapacity of ibandronate in hemodialysis patients [J]. Int J ClinPharmacol Res, 2005, 25(3): 123～131
[12]	Kurth AA, Kim SZ, Shea M, et al. Preventative ibandronate treat-ment has the most beneficial effect on the microstructure of bonein experimental tumor osteolysis[J]. J Bone Miner Metab, 2007, 25(2): 86～92
[13]	程晶, 彭纲, 伍钢, 等. 伊班膦酸钠 (艾本) 治疗骨转移癌的疗效观察 [J]. 中国肿瘤临床,2006,33(18):1073～1075

施引文献

资源附件(0)

计量

文章访问数: 3
HTML全文浏览量: 0
PDF下载量: 1
被引次数: 0

艾本与骨膦治疗非小细胞肺癌骨转移的疗效比较

通讯作者: 郭其森

计量

出版历程

Comparison of the Effects of Ibandronate and Bonefos on Non small Cell Lung Cancer with Bone Metastases

计量

出版历程

目录

通讯作者:
郭其森